Industrial Pharmacy Journal - Issue 57
Published quarterly by Euromed Communicatons in association with the Industrial Pharmacy Section of the FIP. If you are a pharmaceutical scientist or executive working in or liaising with Industry, your job will be made easier, more productive and more enjoyable by reading Industrial Pharmacy.
The journal covers a variety of topics of interest to those working in the worldwide pharma industry. Industrial Pharmacy is published four times a year.
european Industrial Pharmacy is an electronic edition of Industrial Pharmacy published for the European Industrial Pharmacy Group (EIPG) and distributed to its members throughout Europe by e-mail. It contains selected articles from Industrial Pharmacy, plus articles of special interest to European readers, news from the EIPG, etc.
4 PHARMACEUTICAL EXCIPIENT REGULATIONS: HOW THE EXCIPACT CERTIFICATION SCHEME CAN REDUCE THE AUDIT BURDEN FOR BOTH SUPPLIERS AND USERS
A growing list of pharmaceutical excipient suppliers have been certified for GMP and/or GDP by EXCiPACT registered Certification Bodies. This list is being regularly used by MAHs as a reliable source during their supplier qualification process as it offers direct access to audit reports and certificates and has taken the place of many individual audits.
by Tony Scott
7 IS THERE A MISSING PIECE IN THE REGULATORY SYSTEM?
Current regulatory requirements do not include the need to check the quality and integrity of Chemistry, Manufacturing and Control data. The author suggests this is the time for change in attitude and legislation.
by Tony Cartwright
10 DATA INTEGRITY IN THE PHARMACEUTICAL INDUSTRY
Review of the 1st International Conference on Data Integrity in Pharmaceuticals held in London on 2nd March 2018.
by Gary Bird
16 THE IMPACT OF BREXIT ON AVAILABILITY OF PHARMACEUTICALS IN EUROPE
Pharma companies should be acting now to mitigate the effects of the UK’s withdrawal from the European Union.
by John Jolley
18 DISPENSING PROCESS AS A CORNERSTONE OF IMPROVING PHARMACOVIGILANCE
Pharmaceutical companies should be educating the pharmacist on their products and receiving feedback on any adverse reactions.
by Aldo Alvarez-Risco, Shyla Del-Aguila-Arcentales and Santiago Diaz-Risco
3 EDITORIAL COMMENT
23 REGULATORY REVIEW
27 PHARMA IN PLENARY
29 BOTTLED BROWN
32 CORPORATE PROFILES
A free sample copy of the journal can be downloaded in pdf format by clicking the link below. The subscription price is for four issues each year.